Our pipeline is focused on unlocking the science of the immune system and advanced technologies to develop innovative medicines and vaccines
Here, Hesham Abdullah, GSK’s Global Head of Oncology R&D, discusses the leaps forward his team has made, and their ambitions for the future. Read our article Our purpose We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to ...
Our pipeline is focused on unlocking the science of the immune system and advanced technologies to develop innovative medicines and vaccines
However, the number of potential drugs in the pipeline has dwindled. Despite difficulties, some companies, including GSK, are pressing ahead, hoping to revive the field and take on one of the biggest health challenges facing humanity.Read our article on AMR Our purpose We are a focused ...
The world desperately needs new antibiotics to get ahead of the growing threat of pathogens. However, the number of potential drugs in the pipeline has dwindled. Despite difficulties, some companies, including GSK, are pressing ahead, hoping to revive the field and take on one of the biggest ...
However, the number of potential drugs in the pipeline has dwindled. Despite difficulties, some companies, including GSK, are pressing ahead, hoping to revive the field and take on one of the biggest health challenges facing humanity.Read our article on AMR Our purpose We are a focused ...
However, the number of potential drugs in the pipeline has dwindled. Despite difficulties, some companies, including GSK, are pressing ahead, hoping to revive the field and take on one of the biggest health challenges facing humanity.Read our article on AMR Our purpose We are a focused ...
However, the number of potential drugs in the pipeline has dwindled. Despite difficulties, some companies, including GSK, are pressing ahead, hoping to revive the field and take on one of the biggest health challenges facing humanity.Read our article on AMR Our purpose We are a focused ...
However, the number of potential drugs in the pipeline has dwindled. Despite difficulties, some companies, including GSK, are pressing ahead, hoping to revive the field and take on one of the biggest health challenges facing humanity.Read our article on AMR Our purpose We are a focused ...
However, the number of potential drugs in the pipeline has dwindled. Despite difficulties, some companies, including GSK, are pressing ahead, hoping to revive the field and take on one of the biggest health challenges facing humanity.Read our article on AMR Our purpose We are a focused ...